- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure. The role of various diets in PKD disease progression is a hot topic among researchers and clinicians. In addition, a new study established that being overweight and obese are risk factors in PKD progression.1
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
- Nowak K et al, JASN, 2018 Feb; 29(2): 571–578
Featuring
Kristen Nowak, PhD, MPH
Associate ProfessorUniversity of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension*
Kristen Nowak, PhD, MPH, is currently an Associate Professor at the University of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension. She received her PhD from the University of Colorado Boulder in integrative physiology and completed a postdoctoral fellowship (nephrology) and MPH (epidemiology) at the University of Colorado Anschutz Medical Campus. She has been principal investigator or co-investigator for several ongoing and completed ADPKD clinical trials. Her work is supported by funding from the National Institutes of Health and the Polycystic Kidney Disease Foundation. She is particularly focused on the role of lifestyle, including dietary interventions and weight loss, and the progression ADPKD, as well as physiological mechanisms involved. She also directs the Clinical Vascular Physiology Laboratory in the Division of Renal Diseases and Hypertension.
Hannah N. Lambert, PharmD
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
Sachin Hajarnis, PhD
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Sachin Hajarnis, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka.
*Dr Kristen Nowak is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Hannah Lambert and Sachin Hajarnis are employees of OPDC.
If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:
Registration
Related Resources
-
Plant-Based Diets For Kidney Health: Benefits, Examples, & Strategies
Infographic September 6, 2024Learn the known and potential benefits of plant-based diets as well as strategies to mitigate potential downfalls.
-
NephU Infographic – Nutrition & Diet In Patients Receiving Dialysis
Infographic April 3, 2024This infographic provides a breakdown of some nutritional information to consider for patients receiving dialysis.
-
On-Demand Webinar: Nutritional Considerations for Peritoneal Dialysis
On-Demand Webinar March 7, 2024In this on-demand webinar, Drs. Joshi and Shah share their expertise in peritoneal dialysis (PD) and nutrition.
Related Events
-
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
January 8, 2025 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.